Bloomage Showcases New Functional Food Ingredients for the Japanese Market at HI Japan 2024
04 nov. 2024 09h00 HE
|
Bloomage Biotech
Parsippany, New Jersey, USA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Bloomage(SHA: 688363), a global leader in hyaluronic acid and other bioactive substances, continued to promote healthier lifestyles...
Biomaterials Market is Expected to Reach $64.2 billion | MarketsandMarkets™
27 mars 2024 08h30 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, March 27, 2024 (GLOBE NEWSWIRE) -- Biomaterials market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of...
Bloomage receives highest honors from the All-China Women’s Federation
08 mars 2024 09h00 HE
|
Bloomage Biotech
Parsippany, New Jersey, USA, March 08, 2024 (GLOBE NEWSWIRE) -- On this year’s International Women’s Day, one of the world’s premier women-led companies, Bloomage, is being awarded for its...
Bloomage Pledges 24-Hour Client Inquiry Response to Uphold Customer-Centric Focus
17 oct. 2023 09h00 HE
|
Bloomage Biotech
Parsippany, New Jersey, USA, Oct. 17, 2023 (GLOBE NEWSWIRE) -- As a leading biotechnology and biomaterials company, Bloomage has been committed to producing premium hyaluronic acid materials for...
Bloomage Biotech research director discusses female contributions in science on International Women’s Day
08 mars 2023 09h00 HE
|
Bloomage BioTechnology Corporation Limited
Parsippany, New Jersey, USA, March 08, 2023 (GLOBE NEWSWIRE) -- As women are making significant strides in various fields, they inspire others to improve continuously. One such inspirational figure...
Bloomage Biotech receives the PCHi2023 Fountain Awards for innovation exellence
06 mars 2023 10h01 HE
|
Bloomage BioTechnology Corporation Limited
Parsippany, New Jersey, USA, March 06, 2023 (GLOBE NEWSWIRE) -- Bloomage Biotech has been awarded the prestigious Fountain Awards at the Asia-Pacific international event, PCHi, held in Guangzhou...
Riverside Medical Center Performs First In-Patient Use of Biomaterial-Based HydroPICC® Dual Lumen Catheter
12 déc. 2022 08h00 HE
|
Access Vascular
BILLERICA, Mass., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI) today announced that Riverside Medical Center, located just outside the Chicago area, was the first in the nation to...
Access Vascular Integrative Review Published in International Journal of Nursing and Healthcare Research Establishes Economic Impact of Biomaterial Catheters
31 oct. 2022 08h00 HE
|
Access Vascular
BILLERICA, Mass., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications through its advanced biomaterial...
GoodCell Launches in Concierge Practices to Meet the Demand for Proactive & Preventative Longevity Services
20 oct. 2022 07h30 HE
|
GoodCell
Atlanta, GA, Oct. 20, 2022 (GLOBE NEWSWIRE) -- At Concierge Medicine Today’s annual Forum, GoodCell, a life sciences company, launched its Personal Biobanking service in concierge medicine practices...
Journal of Infusion Nursing Publishes Access Vascular Data Showing Significantly Reduced Complication Rates for HydroMID
19 sept. 2022 08h00 HE
|
Access Vascular
BILLERICA, Mass., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications through its advanced biomaterial...